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SUMMARY
Regarding public health in Brazil, a new scenario emerged with the establishment of universal rotavirus (RV) vaccination programs. 
Herein, the data from the five years of surveillance (2007-2012) of G- and P-type RV strains isolated from individuals with acute 
gastroenteritis in Brazil are reported. A total of 6,196 fecal specimens were investigated by ELISA and RT-PCR. RVs were detected 
in 19.1% (1,181/6,196). The peak of RV incidence moved from June-August to September. RV was detected less frequently (19.5%) 
among children ≤ 5 years than in older children and adolescents (6-18 years) (40.6%). Genotype distribution showed a different 
profile for each year: G2P[4] strains were most prevalent during 2007-2010, G9P[8] in 2011, and G12P[8] in 2012. Mixed infections 
(G1+G2P[4], G2+G3P[4]+P[8], G2+G12P[8]), unusual combinations (G1P[4], G2P[6]), and rare strains (G3P[3]) were also identified 
throughout the study period. Widespread vaccination may alter the RV seasonal pattern. The finding of RV disease affecting older 
children and adolescents after vaccine implementation has been reported worldwide. G2P[4] emergence most likely follows a global 
trend seemingly unrelated to vaccination, and G12, apparently, is emerging in the Brazilian population. The rapidly changing RV 
genotype patterns detected during this study illustrate a dynamic population of co-circulating wildtype RVs in Brazil. 
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INTRODUCTION
Rotavirus (RV) disease is a global public health concern, accounting 
for over half a million deaths and two million hospitalizations each 
year36,42. RVs are classified in a binary system based upon the main 
neutralization antigens, namely, the spike protein (VP4) and the major 
outer capsid glycoprotein (VP7). VP7 and VP4 nucleotide sequences 
define G and P genotypes, respectively, and carry independent 
neutralization-specific epitopes. To date, 27 G genotypes (G1-G27) and 
37 P genotypes (P[1]-P[35]) have been described30,45. Globally, most 
human RVs have the genotype combination G1P[8], G2P[4], G3P[8], 
G4P[8] or G9P[8], and studies from all around the world have recently 
shown a high prevalence of G12 strain and its association with multiple 
VP4 genotypes5.
Two safe and effective RV vaccines (RotarixTM, GlaxoSmithKline 
Biologicals, Belgium; and RotaTeqTM, Merck Inc., USA) have been 
licensed in approximately 100 countries worldwide since 2006. These 
vaccines have already been incorporated into the routine immunization 
programs in many countries of the Americas (including Brazil) and 
Europe, as well as in Australia and South Africa48. Brazil’s national 
immunization program introduced RotarixTM vaccine in the childhood 
immunization schedule in March 2006. From 2007 to 2010, administrative 
coverage with the two-dose series of RV vaccine ranged from 80% to 
84% in the country15, and 22% reduction in diarrhea-related mortality 
was observed in children < 5 years during 2007-200912. With the 2009 
World Health Organization (WHO) recommendation for the global use of 
RV vaccines, it is anticipated that these vaccines will soon be introduced 
more widely in immunization programs globally5.
The primary goal of most RV strain surveillance programs is to 
genotype the co-circulating RVs before the introduction of vaccine 
and to monitor vaccine effectiveness5,28,32. Virtually, all such studies 
are conducted on infants43. The RV genotypic diversity in the general 
population has received much less attention. In addition, seasonal 
changes of the predominant RV strains in children in a given geographical 
region and the cross-border migration of RV strains due to population 
movements have also been documented4. However, the issue of whether 
the introduction of new RV strains in children results in disease across 
all age groups is not commonly addressed. 
A new scenario emerged in Brazil with the establishment of a 
universal RV vaccination program, and the consequences on the 
epidemiology of RV infections are still unpredictable13. Continued 
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genotype surveillance is needed to better understand the spread of RV in 
the broader community. The aim of this study was to describe the G and 
P types of RV strains isolated in Brazil during five years of surveillance 
(2007-2012).
MATERIALS AND METHODS
From June 2007 to June 2012, a total of 6,196 fecal specimens 
were collected from children ≤ 5 years of age, school-age children and 
adolescents (6 - 18 years), adults (19 - 59 years), and elderly patients 
(≥ 60 years) with acute gastroenteritis. Epidemiological data (age, date 
of diarrhea onset, date of sample collection) were not available for all 
patients, probably due to insufficient healthcare worker education and 
information. The specimens were stored at –20 °C until tested for RV 
and characterized. 
This is a retrospective and descriptive study conducted with clinical 
samples. Stool samples from patients with acute gastroenteritis were sent 
to the Enteric Diseases Laboratory of the Adolfo Lutz Institute, a regional 
reference center for RV surveillance, credentialed by the Health Ministry 
of Brazil, and a member of the Acute Diarrhea Disease Monitoring 
Program from the State Department of Health. The aim of this program 
is the early detection of diarrhea outbreaks with national scope. In this 
study, clinical samples from Sao Paulo (SP), Mato Grosso (MT), Mato 
Grosso do Sul (MS), Parana (PR), Tocantins (TO), Goias (GO), Santa 
Catarina (SC) States, and Federal District (DF) were analyzed (Fig. 1). 
All specimens were screened for RV using a commercial enzyme-
linked immunosorbent assay (ELISA) (Premier Rotaclone, Meridian 
Diagnostics, Cincinnati, OH, USA) with monoclonal antibodies specific 
for group A human RV, according to the manufacturer’s protocol. RV 
double-stranded RNA (dsRNA) was extracted from the fecal samples 
(diluted in TRIS-HCL 0.001 M, pH 7.3 to obtain a 10% suspension) using 
QIAamp® Viral RNA Mini kit (Qiagen, Valencia, CA, USA), according 
to the manufacturer’s instructions. The extracted dsRNA was subjected 
to G and P typing by multiplex reverse transcription-polymerase chain 
reaction (RT-PCR) with type-specific primers following previously 
described protocols16-18,27. 
RESULTS
The RV was detected in 1,181 (19.1%) of 6,196 specimens collected 
from children, adults, and elderly patients in Brazil during a five-year 
period. RV infection was found predominantly in the winter and in drier 
months. The incidence peaked in September (Fig. 2). The detection rate 
varied according to the year: 23.2% (173/746) in 2007; 25.9% (247/954) 
in 2008; 2.3% (20/877) in 2009; 29.8% (544/1,824) in 2010; 15.8% 
(176/1,111) in 2011; and 3.1% (21/684) in 2012. The age or date of birth 
was provided by 1,150 (97.4%) of 1,181 patients who tested positive for 
RV. RV disease was detected mainly in individuals ≤ 18 years of age, 
and peaks of incidence occurred from six to 18 years (215 [40.6%] of 
529). However, RV infection was also detected in adults and elderly 
patients (Table 1).
A total of 1,054 (89.2%; 1,054/1,181) RV-positive samples were 
randomly selected for determination of G and P genotypes by an RT-
PCR assay. Both RV G and P types could be established in 945 (89.6%; 
945/1,054) strains, and 37 different P and G associations were detected. 
The distribution of RV VP7 types in Brazil during this five-year period 
showed that G2 was the most prevalent genotype from 2007 to 2010; 
however it was displaced by G9 in 2011. In 2012, the emergence of 
G12 strains was observed. The uncommon genotypes G8 and G10 were 
detected between 2009 and 2011, and in 2012, respectively. Considering 
the VP4 protein, P[4] was predominant during 2007-2008, and 2010, P[6] 
in 2009, and P[8] in 2011-2012 (Table 2).
Four of the five most globally common strains, G1P[8], G2P[4], 
G3P[8] and G9P[8] were identified, which represented 74.6% of all 
typed RV strains. Curiously, the 5th most common strain, G4P[8], 
was not identified during the study period. Genotype distribution 
showed a different profile for each year: G2P[4] being most 
Fig. 1 - The States highlighted in black collected stool samples from patients with acute 
gastroenteritis and sent them to the Enteric Diseases Laboratory of the Adolfo Lutz Institute, 
regional reference center for rotavirus surveillance, member of Acute Diarrhea Disease 
Monitoring Program and its national scope. Abbreviations represent the names of Brazilian 
States: Acre (AC), Alagoas (AL), Amapa (AP), Amazonas (AM), Bahia (BA), Ceara (CE), 
Distrito Federal (DF), Espirito Santo (ES), Goias (GO), Maranhao (MA), Mato Grosso 
(MT), Mato Grosso do Sul (MS), Minas Gerais (MG), Para (PA), Paraiba (PB), Parana (PR), 
Pernambuco (PE), Piaui (PI), Rio de Janeiro (RJ), Rio Grande do Norte (RN), Rio Grande 
do Sul (RS), Rondonia (RO), Roraima (RR), Santa Catarina (SC), Sao Paulo (SP), Sergipe 
(SE), and Tocantins (TO). 
Fig. 2 - Temporal distribution of rotavirus strains from children, school children and 
adolescents, adults, and elderly patients with acute diarrhea, Brazil, 2007-2012.
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Table 1
Distribution of RV-positive samples according to age group, Brazil, 2007-2012
Age (years) RV positive (No.) Total of samples (No.) RV positive (%) Total values (%) 
≤5 821 4,213 19.5% 69.5% 
6-18 215 529 40.6% 18.2%
19-59 99 1004 10.0% 8.4%
≥60 15 202 7.4% 1.3%
* 31 248 12.5% 2.6%
Total 1181 6196 19.1% 100%
* Patient age not known.
Table 2
P and G types of RV strains from children, school children and adolescents, adults, and elderly with acute diarrhea, Brazil, 2007-2012
Genotypes 
Year
2007 2008 2009 2010 2011 2012 Total
No. (%) No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
Common human rotavirus genotypes
G1P[8] 22 (17.9) 5 (2.7) - 23 (4.3) - - 50 (4.7)
G2P[4] 74 (60.3) 140 (77.3) 5 (27.8) 325 (60.3) 29 (17.5) 1 (3.8) 574 (54.2)
G3P[8] - 1 (0.5) 3 (16.4) 43 (8.0) 18 (10.8) 3 (11.5) 68 (6.4)
G9P[8] 14 (11.4) 1 (0.5) - 13 (2.4) 66 (39.8) 2 (7.7) 96 (9.1)
Reassortment among common human rotavirus genotypes
G1P[4] 1 (0.8) - - 3 (0.5) - - 4 (0.4)
G3P[4] - - - 22 (4.1) - - 22 (2.1)
G9P[4] - - - 1 (0.2) - - 1 (0.1)
Potential zoonotic rotavirus genotypes
G3P[3] - - - - 1 (0.6) - 1 (0.1)
G3P[6] - - - 2 (0.4) 4 (2.4) - 6 (0.6)
G8P[6] - - 5 (27.8) - - - 5 (0.5)
G12P[9] - - 1 (5.6) - 1 (0.6) 1 (3.8) 3 (0.3)
Possible human-animal hybrid rotavirus genotypes
G2P[6] 1 (0.8) - - - - - 1 (0.1)
G8P[4] - - - 4 (0.7) 1 (0.6) - 5 (0.5)
G12P[4] - - - - - 1 (3.8) 1 (0.1)
G12P[6] - - - - 1 (0.6) - 1 (0.1)
G12P[8] - 1 (0.5) - - 30 (18.1) 12 (46.5) 43 (4.1)
Mixed infections (single G-type with two or more P-types)
G1P[4]+P[8] - - - 1 (0.2) - - 1 (0.1)
G2P[4]+P[8] 1 (0.8) - - 4 (0.7) - - 5 (0.5)
G2P[4]+P[6] - - 1 (5.6) 2 (0.4) - - 3 (0.3)
G3P[4]+P[6] - - - 1 (0.2) - - 1 (0.1)
G3P[4]+P[8] - - - 1 (0.2) - - 1 (0.1)
G9P[4]+P[8] 1 (0.8) - - - - - 1 (0.1)
G9P[6]+P[8] - - 1 (5.6) - - - 1 (0.1)
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Genotypes 
Year
2007 2008 2009 2010 2011 2012 Total
No. (%) No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
Mixed infections (multiple G-types with single P-type)
G1+G2P[4] - - - 18 (3.3) - - 18 (1.7)
G1+G9P[8] - - - 3 (0.5) - - 3 (0.3)
G2+G3P[4] - - - 11 (2.0) - - 11 (1.0)
G2+G3P[8] - - - 2 (0.4) - - 2 (0.2)
G2+G9P[4] 1 (0.8) - - - - - 1 (0.1)
G2+G9P[8] - - - 2 (0.4) - - 2 (0.2)
G2+G12P[4] - - - - - 1 (3.8) 1 (0.1)
G2+G12P[8] - - - - 1 (0.6) - 1 (0.1)
G2+G3+G9P[8] - - - 1 (0.2) - - 1 (0.1)
G1+G2+G3P[4] - - - 3 (0.5) - - 3 (0.3)
Mixed infections (multiple G- and P-types)
G1+G9P[4]+P[8] - - - 1 (0.2) - - 1 (0.1)
G2+G3P[4]+P[6] - - - 3 (0.5) - - 3 (0.3)
G2+G3P[4]+P[8] - - - 2 (0.4) - - 2 (0.2)
Partially typed rotavirus strains
G1P[NT] 1 (0.8) 1 (0.5) - 5 (0.9) - - 7 (0.7)
G1+G9P[NT] - - - 2 (0.4) - - 2 (0.2)
G1+G2+G3P[NT] - - - - 1 (0.6) - 1 (0.1)
G2P[NT] 4 (3.2) 20 (11.0) - 5 (0.9) 3 (1.8) - 32 (3.0)
G2+G12P[NT] - - - - - 1 (3.8) 1 (0.1)
G3P[NT] - - - 2 (0.4) 1 (0.6) 1 (3.8) 4 (0.4)
G3+G12P[NT] - - - - 2 (1.2) - 2 (0.2)
G9P[NT] 3 (2.4) - - 2 (0.4) 2 (1.2) - 7 (0.7)
G10P[NT] - - - - - 1 (3.8) 1 (0.1)
G12P[NT] - 1 (0.5) - - 1 (0.6) 2 (7.7) 4 (0.4)
GNTP[4] - 5 (2.7) - 23 (4.3) 4 (2.4) - 32 (3.0)
GNTP[6] - - 1 (5.6) 1 (0.2) - - 2 (0.2)
GNTP[4]+P[6] - - 1 (5.6) - - - 1 (0.1)
Non-typable strains
GNTP[NT] - 7 (3.8) - 8 (1.5) - - 15 (1.4)
RV positive  123 (100) 182 (100) 18 (100) 539 (100) 166 (100) 26 (100) 1054 (100)
NT* not type.
Table 2
P and G types of RV strains from children, school children and adolescents, adults, and elderly with acute diarrhea, Brazil, 2007-2012 (cont.)
prevalent from 2007 to 2010, G9P[8] in 2011, and G12P[8] in 2012 
(Table 2). 
Mixed infections were observed throughout the analyzed period 
(62/1,054; 5.9%), and could be classified as single G-type with two or 
more P-types, multiple G-types with single P-type or multiple G- and 
P-types (Table 2). These strains are representative of those genotypes seen 
in single infections. RV strains with unusual G/P type combinations were 
also detected (27/1,054; 2.6%), including G1P[4], G3P[4], and G9P[4]. 
Strains whose derivation may be associated with reassortment between 
animal and human strains were 4.8% (51/1,054), and infection with RV 
strains of animal origin represented 1.4% (15/1,054) of strains found 
(Table 2). Table 3 presents the numbers of mixed RV infections which 
could have given rise to particular unusual G/P type combinations by 
reassortment in nature. Using the data of Tables 2 and 3, no significant 
correlation was detected by linear regression analysis (R = 0.638; N = 7).
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DISCUSSION
As universal RV vaccination continues to increase worldwide, global 
surveillance of RV has become an important focus of the vaccination 
programs. RV surveillance is vital to describe genotype distribution 
in different countries and their regions, and to discover potential 
development of new strains11. This study documents the high detection 
rate of G2P[4] strain in Brazil after RV vaccine introduction, as widely 
presented in previous studies8,32; however, also reveals a suggestive trend 
to be replaced by new RV strains (i.e. G9P[8] and G12P[8]) in the most 
recent years. 
RV surveillance, considering the general population in Brazil, is 
patchy, and the majority of studies were performed among children 
under five years of age, even before vaccine introduction8,28,32,44. The 
frequency of RV infection detected in this work (19.1%) was lower than 
global proportions (24.3%), and those observed in studies carried out 
in other Latin America countries: Argentina (28.3%), Bolivia (28.9%), 
Chile (31.1%), Colombia (30%), Costa Rica (44.3%), Ecuador (30.9%), 
Guatemala (30.1%), Panama (24.9%), Paraguay (25.3%), Peru (25.1), 
and Uruguay (37.5%). Nevertheless, the frequency of RV infections 
was similar to that found in Mexico (19.9%) and Nicaragua (19.0%)28.
A previous study conducted in Sao Paulo, Brazil, (1996-2003) 
showed that the RV detection rate in the general population was 25%7. 
The present study (2007-2012) demonstrated a reduction in laboratory-
confirmed RV disease (19.1%) in the country. This data is consistent with 
the decreasing burden of RV disease following vaccine introduction. RVs 
were detected less frequently (19.5%) among children ≤ 5 years of age 
than in older children and adolescents (6-18 years) (40.6%). RV infection 
rates among children ≤ 5 years will probably continue to decrease in 
future years, as successive birth cohorts are vaccinated11. Changes in the 
epidemiology of RV disease might occur in the post-licensing era, such as 
shifts in average age of infected person 39. It has been observed in USA11 
and Brazil13 that RV disease tends to occur in older children after vaccine 
implementation. One possible explanation may be that the indirect 
protection of unvaccinated infants due to reduced RV transmission in 
the community (i.e. herd immunity), resulted in a larger susceptible 
cohort of unvaccinated older children that were not exposed to natural 
RV infection in previous seasons2,11,47. Nonetheless, it is not yet possible 
Table 3
Mixed RV infections that have possibly preceded the emergence of unusual genotypes
Mixed type Total
Unusual genotypes that possibly emerged from mixed infection
G1P[4] G3P[4] G9P[4] G2P[6] G8P[4] G12P[4] G12P[6]
G1P[4]+P[8] 1 Yes --- --- --- --- --- ---
G2P[4]+P[8] 5 --- --- --- --- --- --- ---
G2P[4]+P[6] 3 --- --- --- Yes --- --- ---
G3P[4]+P[6] 1 --- Yes --- --- --- --- ---
G3P[4]+P[8] 1 --- Yes --- --- --- --- ---
G9P[4]+P[8] 1 --- --- Yes --- --- --- ---
G9P[6]+P[8] 1 --- --- --- --- --- --- ---
G1+G2P[4] 18 Yes --- --- --- --- --- ---
G1+G9P[8] 3 --- --- --- --- --- --- ---
G2+G3P[4] 11 --- Yes --- --- --- --- ---
G2+G3P[8] 2 --- --- --- --- --- --- ---
G2+G9P[4] 1 --- --- Yes --- --- --- ---
G2+G9P[8] 2 --- --- --- --- --- --- ---
G2+G12P[4] 1 --- --- --- --- --- Yes ---
G2+G12P[8] 1 --- --- --- --- --- --- ---
G2+G3+G9P[8] 1 --- --- --- --- --- --- ---
G1+G2+G3P[4] 3 Yes Yes --- --- --- --- ---
G1+G9P[4]+P[8] 1 Yes --- Yes --- --- --- ---
G2+G3P[4]+P[6] 3 --- Yes --- Yes --- --- ---
G2+G3P[4]+P[8] 2 --- Yes --- --- --- --- ---
Total 62 23 21 3 6 0 1 0
NOTE. The number of unusual G/P single infections were 4 G1P[4] infections, 22 G3P[4] infections, 1 G9P[4] infection, 1 G2P[6] infection, 5 G8P[4] infections, 
1 G12P[4] infection, and 1 G12P[6] infection. 
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to predict whether the transmission of RV will persist in older age groups 
even with an increase in vaccine coverage among infants. RV vaccination 
effects on household and community transmission will probably fluctuate 
as RV-susceptible children accumulate and become infected41. 
On the other hand, post-vaccination records also indicate large 
reductions in RV disease among members of age groups who are too old 
to be vaccinated, suggesting that infants act as the primary carriers of 
infection39. Indirect protection occurs as a result of decreased transmission 
of the infectious agent in the community, and amplifies the direct benefits 
of vaccination among both vaccinated and unvaccinated individuals3 
which is a phenomenon that was not studied in the clinical trials of either 
vaccines41. Indirect benefits and/or harm from RV vaccination still need 
to be further explored. 
RV infections occurred in the winter months (dry season) as 
usually observed in Brazil, especially in the South, Southeastern, and 
Midwest regions13. Curiously, a particular event was observed. The 
RV detection rate is usually concentrated between June and August in 
Brazil7; nevertheless, the frequency of RV detection in this study peaked 
in September, i.e. at the beginning of the rainy season. The seasonal 
patterns and the influence of climate on many infectious diseases are 
well known40, and global warming is one of the environmental changes 
now under way. Nevertheless, it is still impossible to predict whether 
this climate variation could promote a wide range of impacts upon the 
occurrence of RV infection in the Brazilian population. 
Alternatively, studies from various regions have also identified a 
remarkably consistent finding with regard to timing and spread of RV 
epidemics39. Studies from USA and Belgium showed that a shift in 
the onset of epidemics by one to two months has taken place after RV 
vaccination6,43. Regular annual epidemic dynamics could be driven by 
the accumulation of fully susceptible individuals (i.e. newborns) in the 
population, and widespread vaccination would be expected to reduce the 
number of fully susceptible individuals, thereby delaying the timing of RV 
activity and also potentially altering the seasonal pattern of RV activity 
across the country10. This hypothesis was tested in USA by CURNS et 
al.10 and provides evidences that the spatiotemporal dynamics of RV 
activity are likely driven by the rate of accumulation of fully susceptible 
individuals rather than solely by environmental factors.
Considering RV annual frequency, a low percentage of RV infection 
was observed in 2009 (2.3%). A similar lack of a RV season in Brazil 
during 2009 has been previously described13. The significant decrease 
observed in RV cases in 2009 was not accompanied by a decrease in the 
number of non-RV diarrhea cases, eliminating the possibility of bias due 
to specimen collection (http://portal.saude.gov.br/portal/arquivos/pdf/
casos_dda_16_04_2012.pdf, http://portal.saude.gov.br/portal/arquivos/
pdf/vigilanciadda.pdf). In the following 2010 season, however, Brazil 
experienced the resurgence of RV-associated cases, going back to the 
2008 level of RV diarrhea cases. A substantial reduction in RV activity 
in one season followed by resurgence in the next season after vaccine 
introduction has been reported13,43. In addition, according to the National 
Meteorology Institute (INMET) records, during 2009, Brazil experienced 
an atypical rainy winter season with a higher average rainfall record due 
to the El Niño phenomenon (http://www.inmet.gov.br). Hypothetically, 
this climate condition could be involved in the low detection frequency 
observed. 
Moreover, in 2009, the pandemic influenza A (H1N1) virus spread 
surprisingly quickly, and represented a significant challenge for Brazil’s 
Surveillance Centers, as well as for the surveillance systems worldwide. 
A commitment between the new A/H1N1 pandemic response and the 
ability to continue surveillance efforts for other viruses, including RVs 
was found. A study conducted by COX et al.9 measured the impact of 
H1N1 influenza pandemic on the reporting of other events. The analysis 
revealed that the reporting of other threats dropped to a significantly lower 
rate, suggesting an important impact on the notification process of events 
during a period of extensive mobilization of public health resources9. It is 
noteworthy that a low detection rate was also observed in 2012 (3.1%). 
However, the current study was conducted until June 2012 and therefore 
ended before the beginning of the RV season.
The genotyping results are comparable to recent published Brazilian 
pediatric surveillance genotyping data from 2007 to 2010, including the 
notably marked predominance of G2P[4]13. However, other common 
genotypes (G1P[8], G3P[8], G9P[8]) continued to circulate marginally 
over time, as observed in the Australian RV surveillance program23. 
The emergence of G2P[4] since 2006 has been reported in vaccinated 
populations in Australia (RotarixTM and RotateqTM) and Nicaragua 
(RotateqTM)24,38, but also – to a lesser extent – in non-vaccinated 
populations14. The G2P[4] emergence and high prevalence probably 
follows a global trend dictated by natural oscillatory fluctuations of the 
most prevalent genotypes rather than being an effect of vaccination13.
Strains exhibiting the G8 genotype were identified in 2009, 2010, 
and 2011, following the sporadic identification of G8 strains as a cause 
of acute gastroenteritis in the Brazilian population during 2000-200446. 
The P[3] and P[9] types were also identified during the study period. In 
Brazil, previous reports found P[3] to be associated with G344, and P[9] 
with G1046. Taken together these reports continue to highlight their low 
level existence in Brazilian inhabitants. 
The present surveillance showed that genotype G9P[8] re-emerged 
as the dominant genotype in 2011, representing 39.8% of all strains. 
Genotype G2P[4] was the second predominant type nationally, 
comprising 17.5% of all strains characterized. This survey highlights the 
ongoing fluctuations in the dominant genotypes and reveals the return of 
G9 as the dominant genotype in Brazil, similar to that observed in the 
early 2000s, in the pre-vaccine era7. In Australia, the parallel use of both 
vaccines provides a unique opportunity to compare the effect of each 
vaccine on the circulating wild type strains23. While the absolute numbers 
of RV-associated cases of acute gastroenteritis were reduced in all States, 
G2 and G9 strains were more prevalent in States using RotarixTM, whereas 
G3 strains were more prevalent in States using RotateqTM 25. The relatively 
high prevalence of G9 and G2 RV cases reported in 2011 may reflect a 
similar situation to that observed in Australia after RotarixTM introduction. 
These differences do not necessarily imply a lack of protection against 
a particular type by either vaccine, but rather highlight the variation that 
can occur due to natural annual fluctuation in RV strain prevalence25. 
In the present study, G12 was detected in 4.9% of total cases, being 
20% in 2011 and 61.6% in 2012. Prior to 1998, G12 was considered to 
be a rare type associated with human infections31,35. However, G12 in 
association with P[8] and P[6] is emerging worldwide31,35, and the high 
prevalence of G12 in the last two years of the present survey suggests 
that this type is emerging and circulating in the Brazilian population. 
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In South America, the presence of G12 associated with P[9] has been 
reported in Argentina, Brazil, and Paraguay29. The south region of Brazil 
borders with both Paraguay and Argentina, a fact that could indicate the 
spread of this strain within the southern cone of America by cross-border 
migration29. In fact, the rapid emergence and global spread of G12 strain 
in less than a decade illustrates RV’s potential to evolve23. Future studies 
needs to be carried out in order to access the real emergence of G12 
strains in the country. 
Mixed infections have been observed in many populations, including 
in Brazil1,7,34,44, and might be explained by natural reassortment of 
common strains34. Curiously, in 2010, a high number of atypical mixed 
infections were observed. More mixed genotypes are found when many 
different genotypes co-circulate at the same time. This phenomenon 
is more common in countries in which a greater variation of different 
genotypes combinations is detected, such as in Brazil, but many will lead 
to evolutionary dead ends with only a few viral strains demonstrating 
fitness for transmission to population and emergence to become 
significant human pathogens20. In the series of samples described here, 
this was the case with G3P[4] strains emerging in significant numbers 
in 2010 (Tables 2 and 3). On the other hand, sampling intensity was 
very uneven during the years of observation. Thus, during 2010, more 
than 50% of the RV-positive samples were collected, about one third 
of this number in the years 2008 and 2011, and much less in the other 
years. Simply due to absolute numbers, the greatest diversity of RV 
G/P type combinations was found in 2010. Multiplex RT-PCRs for the 
identification of mixed infections should be used with caution. The 
possibilities of non-specific primer binding, different concentrations 
of RV strains, and risk of contamination (when handling several stool 
samples) have to be considered34. 
Uncommon genotype combinations (G1P[4], G2P[6] or G9P[4]) 
were detected less frequently than in pre-vaccine periods7,44, thus 
suggesting a local decrease in strain diversity; unlike the latest data 
reported by the Australian RV surveillance program26. These less 
commonly found genotypes might be in vivo reassortants22,33. The number 
of mixed infections in our study was not correlated with the number of 
unusual genotypes, which suggests that the frequencies of particular 
mixed infections do not determine the frequencies of particular natural 
reassortants in Brazil; differing to those results observed in Israel33. 
Uncommon RV types continue to be of worldwide interest because of 
the possible impact they may have on RV vaccine programs25. 
G4P[8] RV strains are one of the most common combinations found 
in humans worldwide36,44; however, it was not detected in this study. On 
a global level, the weighted prevalence of G4 decreased slightly during 
1996-20075,33. The seasonal shift of RV strains is a possible mechanism 
used by the virus to evade herd immunity acquired by previous infections, 
and thus, ultimately to persist in the human population37. The changing 
pattern of circulating RV types associated with greatly reduced diversity 
of strains may have important implications for the evolution of RV 
strains13. Moreover, in the present study, RV-positive samples could 
not be genotyped by multiplex RT-PCR. Untypable RVA strains have 
been reported in almost every epidemiological survey around the world, 
regardless of the methodology employed19. The number of untypable G 
type strains (50/1056) and P type (76/1056) was relatively high in the 
present study, considering the available technology nowadays and may 
suggest zoonotic transmission of animal RVs or RV genes for which 
there are no suitable primers in the diagnostic kits. In addition, many 
reports describe that certain PCR primers have become outdated since 
the primer binding sites mutated during co-circulation of wild type RVs 
over the years20,21. 
The data obtained in the present study also suggested that adults and 
elderly are susceptible to the same types of RV during the same season 
of the year as children are, since no differences in the distribution of 
common, mixed, unusual or emerging RV strains were found among 
the distinct age groups. These findings highlight the need for continuing 
surveillance in both pediatric and mature populations to monitor the 
suitability of vaccines.
The present laboratory-based surveillance is not necessarily 
representative of the whole country; however the RV typing results 
from this survey, together with those of previous years, highlight the 
unpredictable nature of changes in the prevalence of RV strains across 
Brazil. In addition, the identification of rare or uncommon VP7 and 
VP4 genotypes further illustrates the diversity of strains capable of 
causing severe disease in the Brazilian population. Population level 
impact data could help to improve our understanding of RV transmission 
dynamics and the full potential of RV vaccines39. The rapidly changing 
genotype patterns do illustrate a more dynamic wild-type population, 
thus suggesting that vaccine pressure may be accelerating the selection 
process. This is supported by the observation of an increase in cases 
among older children, adolescents and adults during the current study 
period26.
In countries with seasonal epidemics of RV and current vaccination 
program such as Brazil, surveillance should be extended to the months 
of the year when RV is not expected to fully understand the public health 
importance of shifts in average of cases and timing of epidemics39. 
Understanding the fluctuations in RV types using multi-center national 
surveillance, will provide valuable insights on vaccine efficacy over the 
next years. Rich genomic diversity along with the detection of unusual 
and mixed strains in Brazil further increases the chances of evolution 
of more novel strains. 
RESUMO
Genótipos de rotavírus circulando no Brasil, 2007-2012: 
implicações para o Programa de Vacinação
Em relação à saúde pública no Brasil, um novo cenário emergiu 
com o estabelecimento dos programas universais de vacinação contra o 
rotavírus (RV). Os resultados de cinco anos (2007-2012) de vigilância 
dos genótipos G e P de cepas de RV detectadas em indivíduos com 
gastroenterite aguda no Brasil são descritos no presente estudo. Um total 
de 6196 amostras fecais foi investigado utilizando ELISA e RT-PCR. RVs 
foram detectados em 19,1% (1181/6196). O pico de incidência de RV se 
deslocou de junho-agosto para setembro. RV foi detectado com menor 
frequência entre crianças ≤ 5 anos (19,5%) quando comparado às crianças 
mais velhas e adolescentes (6-18 anos) (40,6%). A distribuição genotípica 
mostrou um perfil diferente a cada ano: a cepa G2P[4] foi prevalente 
durante 2007-2010, G9P[8] em 2011 e G12P[8] em 2012. Infecções 
mistas (G1+G2P[4], G2+G3P[4]+P[8], G2+G12P[8]), combinações 
não usuais (G1P[4], G2P[6]) e cepas atípicas (G3P[3]) também foram 
identificadas em todo o período do estudo. A vacinação em massa pode 
LUCHS, A.; CILLI, A.; MORILLO, S.G.; CARMONA, R.C.C. & TIMENETSKY, M.C.S.T. - Rotavirus genotypes circulating in Brazil, 2007-2012: implications for the vaccine program. 
Rev. Inst. Med. Trop. Sao Paulo, 57(4): 305-13, 2015.
312
alterar o padrão sazonal do RV. A tendência do RV em infectar crianças 
mais velhas e adolescentes após a implementação da vacina tem sido 
relatada em todo o mundo. A emergência de G2P[4] segue provavelmente 
a tendência mundial e, aparentemente, não está relacionada à vacinação. 
G12 também parece estar emergindo na população brasileira. As rápidas 
mudanças nos padrões de genótipos dos RVs observados durante o 
período desse estudo ilustram a existência de uma população dinâmica 
de cepas selvagens co-circulando no Brasil.
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